Off-Label Uses of Medication and Therapies in Wound Care

被引：0
|
作者：
Treadwell, Terry [1 ]
机构：
[1] Inst Adv Wound Care, Montgomery, AL USA
来源：
WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE | 2010年 / 22卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [21] Nonstandard and off-label therapies for psoriasis
    Halverstam, Caroline P.
    Lebwohl, Mark
    CLINICS IN DERMATOLOGY, 2008, 26 (05) : 546 - 553
  • [22] Controlling Off-Label Medication Use
    Gillick, Muriel R.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (05) : 344 - 347
  • [23] OFF-LABEL MEDICATION USE IN ADULT CRITICAL CARE PATIENTS.
    Lat, Ishaq
    Micek, Scott
    Cohen, Henry
    Olsen, Keith
    Haas, Curtis
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A85 - A85
  • [24] Ivabradine: A Review of Labeled and Off-Label Uses
    Oliphant, Carrie S.
    Owens, Ryan E.
    Bolorunduro, Oluwaseyi B.
    Jha, Sunil K.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (05) : 337 - 347
  • [25] Common Drugs with Effective Off-Label Uses
    Alshehri, Mohammed M.
    Mudawi, Mahmoud M. E.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (10)
  • [26] Questions to Ponder Concerning Off-Label Uses
    John C. Hansen
    Drug information journal : DIJ / Drug Information Association, 1998, 32 (2): : 383 - 384
  • [27] Questions to ponder concerning off-label uses
    Hansen, JC
    DRUG INFORMATION JOURNAL, 1998, 32 (02): : 383 - 384
  • [28] Ivabradine: A Review of Labeled and Off-Label Uses
    Carrie S. Oliphant
    Ryan E. Owens
    Oluwaseyi B. Bolorunduro
    Sunil K. Jha
    American Journal of Cardiovascular Drugs, 2016, 16 : 337 - 347
  • [29] Polidocanol: A Review of Off-Label Dermatologic Uses
    Nguyen, Quoc-Bao D.
    Stender, Carly
    Bur, Delfina
    Silapunt, Sirunya
    DERMATOLOGIC SURGERY, 2022, 48 (09) : 961 - 966
  • [30] New and Off-Label Uses of Tranexamic Acid
    Johnson, Stephanie M.
    Tsang, Dawn
    Dansby, Mary
    Allen, Christopher
    AACN ADVANCED CRITICAL CARE, 2021, 32 (03) : 237 - 242
12345